CA2509199A1 - Technique de genie chromosomique - Google Patents
Technique de genie chromosomique Download PDFInfo
- Publication number
- CA2509199A1 CA2509199A1 CA002509199A CA2509199A CA2509199A1 CA 2509199 A1 CA2509199 A1 CA 2509199A1 CA 002509199 A CA002509199 A CA 002509199A CA 2509199 A CA2509199 A CA 2509199A CA 2509199 A1 CA2509199 A1 CA 2509199A1
- Authority
- CA
- Canada
- Prior art keywords
- recombination
- promoter
- region
- bacterial
- site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 121
- 230000002759 chromosomal effect Effects 0.000 title claims description 128
- 230000006798 recombination Effects 0.000 claims abstract description 239
- 238000005215 recombination Methods 0.000 claims abstract description 238
- 230000010354 integration Effects 0.000 claims abstract description 79
- 210000003578 bacterial chromosome Anatomy 0.000 claims abstract description 60
- 230000001580 bacterial effect Effects 0.000 claims abstract description 58
- 102000018120 Recombinases Human genes 0.000 claims abstract description 46
- 108010091086 Recombinases Proteins 0.000 claims abstract description 46
- 108090000623 proteins and genes Proteins 0.000 claims description 163
- 239000012634 fragment Substances 0.000 claims description 145
- 239000003550 marker Substances 0.000 claims description 112
- 239000013612 plasmid Substances 0.000 claims description 69
- 210000004027 cell Anatomy 0.000 claims description 63
- 210000000349 chromosome Anatomy 0.000 claims description 51
- 108010052160 Site-specific recombinase Proteins 0.000 claims description 50
- 230000001105 regulatory effect Effects 0.000 claims description 31
- 102000004190 Enzymes Human genes 0.000 claims description 28
- 108090000790 Enzymes Proteins 0.000 claims description 28
- 241000589344 Methylomonas Species 0.000 claims description 28
- 238000011144 upstream manufacturing Methods 0.000 claims description 27
- 230000015572 biosynthetic process Effects 0.000 claims description 23
- 108700026244 Open Reading Frames Proteins 0.000 claims description 22
- 230000003115 biocidal effect Effects 0.000 claims description 22
- -1 coding sequences Proteins 0.000 claims description 11
- 230000001131 transforming effect Effects 0.000 claims description 11
- 241000701988 Escherichia virus T5 Species 0.000 claims description 8
- 241000607142 Salmonella Species 0.000 claims description 5
- 241000589291 Acinetobacter Species 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 4
- 241000589516 Pseudomonas Species 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 241000701867 Enterobacteria phage T7 Species 0.000 claims 2
- 241000588722 Escherichia Species 0.000 claims 2
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 230000006801 homologous recombination Effects 0.000 abstract description 48
- 238000002744 homologous recombination Methods 0.000 abstract description 48
- 238000010367 cloning Methods 0.000 abstract description 14
- 230000002068 genetic effect Effects 0.000 abstract description 10
- 230000009471 action Effects 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 190
- 241000588724 Escherichia coli Species 0.000 description 85
- 229930027917 kanamycin Natural products 0.000 description 83
- 229960000318 kanamycin Drugs 0.000 description 83
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 83
- 229930182823 kanamycin A Natural products 0.000 description 83
- 101150056470 dxs gene Proteins 0.000 description 56
- 101150000046 crtE gene Proteins 0.000 description 46
- 238000004519 manufacturing process Methods 0.000 description 34
- 235000021466 carotenoid Nutrition 0.000 description 31
- 101100114901 Streptomyces griseus crtI gene Proteins 0.000 description 30
- 150000001747 carotenoids Chemical class 0.000 description 30
- 230000014509 gene expression Effects 0.000 description 29
- 239000000047 product Substances 0.000 description 28
- 102000053602 DNA Human genes 0.000 description 26
- 101100278777 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) dxs1 gene Proteins 0.000 description 26
- 230000037452 priming Effects 0.000 description 26
- 101150075592 idi gene Proteins 0.000 description 25
- 241000932831 Pantoea stewartii Species 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 24
- 230000004048 modification Effects 0.000 description 22
- 238000012986 modification Methods 0.000 description 22
- 230000009466 transformation Effects 0.000 description 19
- 239000013598 vector Substances 0.000 description 19
- 239000002773 nucleotide Substances 0.000 description 18
- 125000003729 nucleotide group Chemical group 0.000 description 18
- 108091028043 Nucleic acid sequence Proteins 0.000 description 16
- 238000010222 PCR analysis Methods 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 15
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 15
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 14
- 108091026890 Coding region Proteins 0.000 description 14
- 150000007523 nucleic acids Chemical class 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 101100286286 Dictyostelium discoideum ipi gene Proteins 0.000 description 12
- 101150014423 fni gene Proteins 0.000 description 12
- 238000001727 in vivo Methods 0.000 description 12
- 150000003505 terpenes Chemical class 0.000 description 12
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 11
- 230000027455 binding Effects 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 238000012408 PCR amplification Methods 0.000 description 10
- 108091081024 Start codon Proteins 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 9
- 239000011543 agarose gel Substances 0.000 description 9
- 229960005091 chloramphenicol Drugs 0.000 description 9
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000008030 elimination Effects 0.000 description 9
- 238000003379 elimination reaction Methods 0.000 description 9
- 235000012661 lycopene Nutrition 0.000 description 9
- 239000001751 lycopene Substances 0.000 description 9
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 9
- 229960004999 lycopene Drugs 0.000 description 9
- 230000037361 pathway Effects 0.000 description 9
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 9
- 108020004705 Codon Proteins 0.000 description 8
- 108091035707 Consensus sequence Proteins 0.000 description 8
- 238000004520 electroporation Methods 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 101001010097 Shigella phage SfV Bactoprenol-linked glucose translocase Proteins 0.000 description 7
- 229960000723 ampicillin Drugs 0.000 description 7
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 108091008053 gene clusters Proteins 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 210000003705 ribosome Anatomy 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 239000013613 expression plasmid Substances 0.000 description 6
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 5
- 108700010070 Codon Usage Proteins 0.000 description 5
- 108020004635 Complementary DNA Proteins 0.000 description 5
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 5
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 5
- NUHSROFQTUXZQQ-UHFFFAOYSA-N Isopentenyl diphosphate Natural products CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 5
- 241000520272 Pantoea Species 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000009833 condensation Methods 0.000 description 5
- 230000005494 condensation Effects 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- CBIDRCWHNCKSTO-UHFFFAOYSA-N prenyl diphosphate Chemical compound CC(C)=CCO[P@](O)(=O)OP(O)(O)=O CBIDRCWHNCKSTO-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 4
- 108020005544 Antisense RNA Proteins 0.000 description 4
- 101150028535 CRTZ gene Proteins 0.000 description 4
- 108010042407 Endonucleases Proteins 0.000 description 4
- 102000004533 Endonucleases Human genes 0.000 description 4
- 241001288713 Escherichia coli MC1061 Species 0.000 description 4
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 4
- 108010066605 Geranylgeranyl-Diphosphate Geranylgeranyltransferase Proteins 0.000 description 4
- 101710173432 Phytoene synthase Proteins 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 4
- 108020004682 Single-Stranded DNA Proteins 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 150000001746 carotenes Chemical class 0.000 description 4
- 239000003184 complementary RNA Substances 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 3
- 108091029865 Exogenous DNA Proteins 0.000 description 3
- 108010046276 FLP recombinase Proteins 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 3
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 3
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 3
- 102000001218 Rec A Recombinases Human genes 0.000 description 3
- 108010055016 Rec A Recombinases Proteins 0.000 description 3
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 3
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 3
- 230000003190 augmentative effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 101150022865 crtX gene Proteins 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 238000007429 general method Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 108060004506 lycopene beta-cyclase Proteins 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000012269 metabolic engineering Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 235000008210 xanthophylls Nutrition 0.000 description 3
- 150000003735 xanthophylls Chemical class 0.000 description 3
- 235000010930 zeaxanthin Nutrition 0.000 description 3
- 239000001775 zeaxanthin Substances 0.000 description 3
- 229940043269 zeaxanthin Drugs 0.000 description 3
- IGUZJYCAXLYZEE-MGVUJODPSA-N (3S,4R)-1-deuterio-3,4,5-trihydroxypentan-2-one Chemical compound C(C(=O)[C@@H](O)[C@H](O)CO)[2H] IGUZJYCAXLYZEE-MGVUJODPSA-N 0.000 description 2
- ATCICVFRSJQYDV-UHFFFAOYSA-N (6E,8E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,26,30-dodecaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C ATCICVFRSJQYDV-UHFFFAOYSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 2
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 2
- 101100397224 Bacillus subtilis (strain 168) isp gene Proteins 0.000 description 2
- 101150012516 CYIB gene Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 101100101368 Escherichia coli (strain K12) uacT gene Proteins 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- GVVPGTZRZFNKDS-YFHOEESVSA-N Geranyl diphosphate Natural products CC(C)=CCC\C(C)=C/COP(O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-YFHOEESVSA-N 0.000 description 2
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 description 2
- 102100039291 Geranylgeranyl pyrophosphate synthase Human genes 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- PKVZBNCYEICAQP-UHFFFAOYSA-N Mecamylamine hydrochloride Chemical compound Cl.C1CC2C(C)(C)C(NC)(C)C1C2 PKVZBNCYEICAQP-UHFFFAOYSA-N 0.000 description 2
- 241000588912 Pantoea agglomerans Species 0.000 description 2
- 241000588696 Pantoea ananatis Species 0.000 description 2
- 108020005091 Replication Origin Proteins 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 101100052502 Shigella flexneri yciB gene Proteins 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 101150073130 ampR gene Proteins 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 101150085103 crtY gene Proteins 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000003209 gene knockout Methods 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 101150064873 ispA gene Proteins 0.000 description 2
- 108060004507 lycopene cyclase Proteins 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000000243 photosynthetic effect Effects 0.000 description 2
- 235000011765 phytoene Nutrition 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 108010060747 zeaxanthin glucosyltransferase Proteins 0.000 description 2
- BIWLELKAFXRPDE-UHFFFAOYSA-N zeta-Carotene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)CCC=C(C)CCC=C(C)C BIWLELKAFXRPDE-UHFFFAOYSA-N 0.000 description 2
- RVCNKTPCHZNAAO-UZDKSQMHSA-N (1R,2R,3R)-prephytoene diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\[C@@H]1[C@@H](COP(O)(=O)OP(O)(O)=O)[C@]1(C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C RVCNKTPCHZNAAO-UZDKSQMHSA-N 0.000 description 1
- BIIBYWQGRFWQKM-JVVROLKMSA-N (2S)-N-[4-(cyclopropylamino)-3,4-dioxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-2-[[(E)-3-(2,4-dichlorophenyl)prop-2-enoyl]amino]-4,4-dimethylpentanamide Chemical compound CC(C)(C)C[C@@H](C(NC(C[C@H](CCN1)C1=O)C(C(NC1CC1)=O)=O)=O)NC(/C=C/C(C=CC(Cl)=C1)=C1Cl)=O BIIBYWQGRFWQKM-JVVROLKMSA-N 0.000 description 1
- OINNEUNVOZHBOX-QIRCYJPOSA-K 2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-) Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP([O-])(=O)OP([O-])([O-])=O OINNEUNVOZHBOX-QIRCYJPOSA-K 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 101100172879 Caenorhabditis elegans sec-5 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 238000007900 DNA-DNA hybridization Methods 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 108700034637 EC 3.2.-.- Proteins 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- YTZIWAULTIDEEY-UHFFFAOYSA-N Isomeres zeta-Carotin Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C YTZIWAULTIDEEY-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108091027974 Mature messenger RNA Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000589350 Methylobacter Species 0.000 description 1
- 241000589342 Methylomonas sp. Species 0.000 description 1
- 241000589354 Methylosinus Species 0.000 description 1
- ATCICVFRSJQYDV-DDRHJXQASA-N Neurosporene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C ATCICVFRSJQYDV-DDRHJXQASA-N 0.000 description 1
- 241000480238 Nidula Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 102000009661 Repressor Proteins Human genes 0.000 description 1
- 108010034634 Repressor Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 108091006088 activator proteins Proteins 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000019730 animal feed additive Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 101150113996 bet gene Proteins 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- OVSVTCFNLSGAMM-KGBODLQUSA-N cis-phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/C=C/C=C(C)/CCC=C(/C)CCC=C(C)C)C)C)C)C OVSVTCFNLSGAMM-KGBODLQUSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- BIWLELKAFXRPDE-PCYOLSTGSA-N di-cis-zeta-carotene Natural products CC(C)=CCCC(C)=CCCC(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(\C)CCC=C(C)CCC=C(C)C BIWLELKAFXRPDE-PCYOLSTGSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000001214 effect on cellular process Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000000369 enteropathogenic effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000012246 gene addition Methods 0.000 description 1
- OINNEUNVOZHBOX-KGODAQDXSA-N geranylgeranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C\CC\C(C)=C\CO[P@@](O)(=O)OP(O)(O)=O OINNEUNVOZHBOX-KGODAQDXSA-N 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000008665 neurosporene Nutrition 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 235000002677 phytofluene Nutrition 0.000 description 1
- OVSVTCFNLSGAMM-UZFNGAIXSA-N phytofluene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=C\C=C(/C)\C=C\C=C(C)CCC=C(C)CCC=C(C)C OVSVTCFNLSGAMM-UZFNGAIXSA-N 0.000 description 1
- ZYSFBWMZMDHGOJ-SGKBLAECSA-N phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)C=CC=C(/C)CCC=C(C)C)C)C)C)C ZYSFBWMZMDHGOJ-SGKBLAECSA-N 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000019525 primary metabolic process Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 235000019529 tetraterpenoid Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- ZIUDAKDLOLDEGU-UHFFFAOYSA-N trans-Phytofluen Natural products CC(C)=CCCC(C)CCCC(C)CC=CC(C)=CC=CC=C(C)C=CCC(C)CCCC(C)CCC=C(C)C ZIUDAKDLOLDEGU-UHFFFAOYSA-N 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- BIWLELKAFXRPDE-XXKNMTJFSA-N zeta-Carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)\C)(\C=C\C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)/C BIWLELKAFXRPDE-XXKNMTJFSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
La présente invention concerne une technique permettant l'intégration d'éléments génétiques étrangers dans un chromosome bactérien sans recourir à une étape de clonage. Cette technique repose sur la présence du système de recombinase ?-Red Dans un hôte bactérien expert en recombinaison. Au moins deux éléments ou construits de recombinaison linéaire sont transformés ensemble dans l'hôte expert en recombinaison et sont assemblés dans l'orientation de correction dans le chromosome bactérien par recombinaison homologue. Des marqueurs sélectionnables utilisés la sélection de transformants sont excisés ensuite par l'action d'une recombinaison spécifique du site.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43460202P | 2002-12-19 | 2002-12-19 | |
| US60/434,602 | 2002-12-19 | ||
| PCT/US2003/041810 WO2004056973A2 (fr) | 2002-12-19 | 2003-12-19 | Technique de genie chromosomique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2509199A1 true CA2509199A1 (fr) | 2004-07-08 |
Family
ID=32682075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002509199A Abandoned CA2509199A1 (fr) | 2002-12-19 | 2003-12-19 | Technique de genie chromosomique |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040209370A1 (fr) |
| EP (1) | EP1573007A4 (fr) |
| JP (1) | JP2006510374A (fr) |
| AU (1) | AU2003302276A1 (fr) |
| CA (1) | CA2509199A1 (fr) |
| WO (1) | WO2004056973A2 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0414832D0 (en) | 2004-07-01 | 2004-08-04 | Cobra Biolog Ltd | Process for the removal of selectable marker gene sequences |
| DK1805296T3 (da) * | 2004-10-22 | 2010-01-18 | Novozymes As | Stabil genomisk integrering af multipie polynukleotidkopier |
| NZ599345A (en) | 2005-02-18 | 2013-07-26 | Novartis Vaccines & Diagnostic | Immunogens from uropathogenic Escherichia Coli |
| AU2006214064B2 (en) | 2005-02-18 | 2012-04-26 | J. Craig Venter Institute, Inc. | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
| US7700328B2 (en) | 2006-06-07 | 2010-04-20 | E.I. Du Pont De Nemours And Company | Method for producing an L-tyrosine over-producing bacterial strain |
| WO2008020330A2 (fr) | 2006-08-16 | 2008-02-21 | Novartis Ag | Immunogènes pour escherichia coli uropathogène |
| JP5837747B2 (ja) | 2007-05-17 | 2015-12-24 | ベーリンガー インゲルハイム エルツェーファウ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 組換えタンパク質を工業規模で製造する方法 |
| WO2008153731A1 (fr) * | 2007-05-24 | 2008-12-18 | Nature Technology Corporation | Méthodes de mise au point améliorée de souches par génie génétique |
| BRPI1102019A2 (pt) * | 2011-04-19 | 2013-06-25 | Unicamp | processo de construÇço de linhagem atenuada mutante de uma bactÉria patogÊnica, vacina, vetor vacinal e uso da referida vacina |
| BR102014030638B1 (pt) * | 2014-12-08 | 2022-12-06 | Universidade Estadual De Campinas - Unicamp | Uso da linhagem salmonella enterica typhimurium para preparar vacina contra salmonelose |
| AU2022211795A1 (en) * | 2021-08-06 | 2023-02-23 | Syte.Bio Inc. | Hairpin loop ended self-complementary double-stranded covalently closed linear dna vector, manufacturing system and process, and uses of said resulting dna vector |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5122457A (en) * | 1989-10-19 | 1992-06-16 | Schering Corporation | Expression systems utilizing bacteriophage t7 promoters, gene sequences, and t7 rna polymerase |
| DK0937098T3 (da) * | 1995-06-07 | 2002-12-02 | Invitrogen Corp | Rekombinatorisk kloning under anvendelse af gensplejsede rekombinationssites |
| AUPN631495A0 (en) * | 1995-11-02 | 1995-11-23 | Commonwealth Scientific And Industrial Research Organisation | Vaccine and biological vector(I) |
| AU752105B2 (en) * | 1997-12-05 | 2002-09-05 | Europaisches Laboratorium Fur Molekularbiologie (Embl) | Novel dna cloning method |
| CA2324648C (fr) * | 1998-03-27 | 2013-02-26 | Prolume, Ltd. | Luciferases, proteines fluorescentes, acides nucleiques codant pour les luciferases et les proteines fluorescentes, et leur utilisation dans des diagnostics |
| AU4694399A (en) * | 1998-06-17 | 2000-01-05 | Iconix Pharmaceuticals, Inc. | Vector construction by host cell-mediated recombination |
| US6355412B1 (en) * | 1999-07-09 | 2002-03-12 | The European Molecular Biology Laboratory | Methods and compositions for directed cloning and subcloning using homologous recombination |
| US20020187544A1 (en) * | 2001-04-05 | 2002-12-12 | Wisconsin Alumni Research Foundation | Uropathogenic E. coli D-serine detoxification operon |
| US20040043003A1 (en) * | 2002-01-31 | 2004-03-04 | Wei Chen | Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
| US20040219629A1 (en) * | 2002-12-19 | 2004-11-04 | Qiong Cheng | Increasing carotenoid production in bacteria via chromosomal integration |
-
2003
- 2003-12-12 US US10/734,936 patent/US20040209370A1/en not_active Abandoned
- 2003-12-19 CA CA002509199A patent/CA2509199A1/fr not_active Abandoned
- 2003-12-19 WO PCT/US2003/041810 patent/WO2004056973A2/fr not_active Ceased
- 2003-12-19 AU AU2003302276A patent/AU2003302276A1/en not_active Abandoned
- 2003-12-19 EP EP03810091A patent/EP1573007A4/fr not_active Withdrawn
- 2003-12-19 JP JP2004561467A patent/JP2006510374A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003302276A1 (en) | 2004-07-14 |
| EP1573007A4 (fr) | 2006-05-10 |
| WO2004056973A2 (fr) | 2004-07-08 |
| JP2006510374A (ja) | 2006-03-30 |
| WO2004056973A3 (fr) | 2005-02-24 |
| EP1573007A2 (fr) | 2005-09-14 |
| US20040209370A1 (en) | 2004-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20040219629A1 (en) | Increasing carotenoid production in bacteria via chromosomal integration | |
| KR102493174B1 (ko) | 고암모니아혈증과 관련된 질병을 치료하기 위해 공학처리된 박테리아 | |
| KR102092422B1 (ko) | 유전자 조작된 미생물로부터 뮤콘산의 생산 | |
| AU2016339989B2 (en) | Genetically engineered bacterium comprising energy-generating fermentation pathway | |
| US20040209370A1 (en) | Method for chromosomal engineering | |
| KR101420889B1 (ko) | 생물 유기 화합물을 제조하기 위한 장치 | |
| KR101417146B1 (ko) | 이소프레노이드의 생산 방법 | |
| KR101377582B1 (ko) | 디엔에이 모듈 클로닝 벡터 플라스미드 및 그의 용도 | |
| CA2682480A1 (fr) | Enzyme pour la production d'une methylmalonyl-coenzyme a ou d'une ethylmalonyl-coenzyme a et son utilisation | |
| KR20220109395A (ko) | 실로시빈 및 중간체 또는 부산물의 생산 방법 | |
| US20100267093A1 (en) | Enhanced homologous recombination mediated by lambda recombination proteins | |
| KR101546885B1 (ko) | 오일 생성능을 가지는 미생물을 이용한 지방산 알킬에스테르의 제조방법 | |
| KR20190003939A (ko) | 유전자 조작된 미생물로부터 개선된 뮤콘산 생산 | |
| CN101617040A (zh) | △17去饱和酶及其在制备多不饱和脂肪酸中的用途 | |
| US20040268436A1 (en) | Method for production of C30-aldehyde carotenoids | |
| CN108949825A (zh) | 一种靶向her2的car-t细胞的制备方法及应用 | |
| CN111088176B (zh) | 产β-胡萝卜素的基因工程菌及其应用 | |
| CN115698297A (zh) | 多模块生物合成酶基因组合文库的制备方法 | |
| CN114231562A (zh) | 一种表达荧光素酶基因的淋巴脉络丛脑膜炎病毒及其构建方法和应用 | |
| US20040209365A1 (en) | Parallel chromosomal stacking of traits in bacteria | |
| CN114134141A (zh) | 一种引入非天然氨基酸的嵌合体苯丙氨酸翻译系统及其构建方法 | |
| CN101065668A (zh) | 基于转录干扰基因沉默的双杂交系统 | |
| KR20160006030A (ko) | CoA 아실화 알데히드 데히드게나제 활성이 증가된 신규한 아크릴산 생성 경로를 갖는 미생물 및 이를 이용한 아크릴산 생산 방법 | |
| CN110804098B (zh) | 一种bk通道光控调节元件 | |
| Karim | Developing Modern Tools for Metabolic Engineering in a Non-Traditional Host: Fine-Tuned Protein Production in Methanosarcina acetivorans C2A |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |